CA Stock MarketDetailed Quotes

KETA TripSitter Clinic Ltd

Watchlist
  • 0.040
  • 0.0000.00%
15min DelayMarket Closed Apr 12 09:30 ET
266.33KMarket Cap-816P/E (TTM)

TripSitter Clinic Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Apr 30, 2024
(FY)Jan 31, 2024
(Q4)Jan 31, 2024
(Q3)Oct 31, 2023
(Q2)Jul 31, 2023
(Q1)Apr 30, 2023
(FY)Jan 31, 2023
(Q4)Jan 31, 2023
(Q3)Oct 31, 2022
(Q2)Jul 31, 2022
Total revenue
0
-97.14%13.98K
-186.83%-8.2K
-99.48%672
-100.00%1
-87.08%21.5K
459.84%488.3K
-82.92%9.44K
344.01%130.39K
6,955.91%182.11K
Operating revenue
--0
-97.14%13.98K
-186.83%-8.2K
-99.48%672
-100.00%1
-87.08%21.5K
459.84%488.3K
-82.92%9.44K
344.01%130.39K
6,955.91%182.11K
Cost of revenue
Gross profit
Operating expense
-48.88%22.66K
-84.57%362.46K
-42.12%169.82K
-80.29%85.88K
-90.02%62.42K
-95.54%44.33K
-0.53%2.35M
-75.73%293.39K
-5.69%435.8K
131.73%625.27K
Selling and administrative expenses
-46.02%22.66K
-80.33%357.34K
-42.12%178.03K
-69.25%85.48K
-89.73%51.85K
-94.87%41.98K
-20.45%1.82M
-74.04%307.56K
-35.94%278.02K
105.30%504.7K
-Selling and marketing expense
--0
-99.13%4.26K
-100.00%3
-99.63%129
-99.92%56
-98.05%4.07K
78.23%486.61K
-16.30%174.23K
-9.04%34.85K
246.05%69.44K
-General and administrative expense
-40.23%22.66K
-73.45%353.08K
33.51%178.02K
-64.90%85.35K
-88.10%51.79K
-93.79%37.92K
-33.85%1.33M
-86.34%133.34K
-38.54%243.17K
92.79%435.25K
Research and development costs
--0
-98.92%3.1K
100.02%2
-99.88%94
-98.58%655
-98.67%2.35K
--286.27K
73.30%-13.27K
176.84%77.41K
133.14%46.01K
Other operating expenses
----
-99.18%2.02K
-813.59%-8.2K
-99.61%310
----
----
214.01%246.38K
-101.21%-898
56,104.90%80.37K
1,652.36%74.56K
Operating profit
0.76%-22.66K
81.27%-348.48K
37.31%-178.02K
72.10%-85.21K
85.92%-62.42K
97.24%-22.84K
18.19%-1.86M
75.39%-283.95K
29.42%-305.42K
-65.82%-443.15K
Net non-operating interest income (expenses)
Other net income (expenses)
623.28%43.62K
66.98%-2.42K
109.26%1.57K
183.32%48.05K
-255.51%-3.58K
99.90%-8.34K
99.91%-7.33K
-16.96K
16.96K
Gain on sale of security
----
-90.57%181
--0
----
----
----
124.94%1.92K
178.18%2.93K
---16.96K
--16.96K
Special income (charges)
----
547.45%45.89K
100.30%31
--1.39K
--48.05K
---3.58K
99.87%-10.26K
---10.26K
----
----
-Less:Restructuring and mergern&acquisition
----
----
----
----
----
--3.58K
----
----
----
----
-Less:Impairment of capital assets
----
--0
----
----
----
----
--37.26K
----
----
----
-Less:Other special charges
----
-69.95%-45.89K
---31
---1.39K
----
----
---27K
----
----
----
Other non-operating income (expenses)
----
---2.45K
----
----
----
----
----
----
----
----
Income before tax
14.21%-22.66K
83.69%-304.86K
38.05%-180.44K
74.06%-83.64K
96.63%-14.37K
96.81%-26.42K
81.71%-1.87M
96.80%-291.28K
25.50%-322.38K
-59.48%-426.2K
Income tax
Earnings from equity interest net of tax
Net income
14.21%-22.66K
83.69%-304.86K
38.05%-180.44K
74.06%-83.64K
96.63%-14.37K
96.81%-26.42K
81.71%-1.87M
96.80%-291.28K
25.50%-322.38K
-59.48%-426.2K
Net income continuous operations
14.21%-22.66K
83.69%-304.86K
38.05%-180.44K
74.06%-83.64K
96.63%-14.37K
96.81%-26.42K
81.71%-1.87M
96.80%-291.28K
25.50%-322.38K
-59.48%-426.2K
Noncontrolling interests
Net income attributable to the company
14.21%-22.66K
83.69%-304.86K
38.05%-180.44K
74.06%-83.64K
96.63%-14.37K
96.81%-26.42K
81.71%-1.87M
96.80%-291.28K
25.50%-322.38K
-59.48%-426.2K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
14.21%-22.66K
83.69%-304.86K
38.05%-180.44K
74.06%-83.64K
96.63%-14.37K
96.81%-26.42K
81.71%-1.87M
96.80%-291.28K
25.50%-322.38K
-59.48%-426.2K
Diluted earnings per share
14.19%-0.0034
82.14%-0.05
-50.00%-0.03
72.25%-0.0139
95.68%-0.0022
97.36%-0.004
86.34%-0.28
98.67%-0.02
30.11%-0.05
-13.16%-0.05
Basic earnings per share
14.19%-0.0034
82.14%-0.05
-50.00%-0.03
72.25%-0.0139
95.68%-0.0022
97.36%-0.004
86.34%-0.28
98.67%-0.02
30.11%-0.05
-13.16%-0.05
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Apr 30, 2024(FY)Jan 31, 2024(Q4)Jan 31, 2024(Q3)Oct 31, 2023(Q2)Jul 31, 2023(Q1)Apr 30, 2023(FY)Jan 31, 2023(Q4)Jan 31, 2023(Q3)Oct 31, 2022(Q2)Jul 31, 2022
Total revenue 0-97.14%13.98K-186.83%-8.2K-99.48%672-100.00%1-87.08%21.5K459.84%488.3K-82.92%9.44K344.01%130.39K6,955.91%182.11K
Operating revenue --0-97.14%13.98K-186.83%-8.2K-99.48%672-100.00%1-87.08%21.5K459.84%488.3K-82.92%9.44K344.01%130.39K6,955.91%182.11K
Cost of revenue
Gross profit
Operating expense -48.88%22.66K-84.57%362.46K-42.12%169.82K-80.29%85.88K-90.02%62.42K-95.54%44.33K-0.53%2.35M-75.73%293.39K-5.69%435.8K131.73%625.27K
Selling and administrative expenses -46.02%22.66K-80.33%357.34K-42.12%178.03K-69.25%85.48K-89.73%51.85K-94.87%41.98K-20.45%1.82M-74.04%307.56K-35.94%278.02K105.30%504.7K
-Selling and marketing expense --0-99.13%4.26K-100.00%3-99.63%129-99.92%56-98.05%4.07K78.23%486.61K-16.30%174.23K-9.04%34.85K246.05%69.44K
-General and administrative expense -40.23%22.66K-73.45%353.08K33.51%178.02K-64.90%85.35K-88.10%51.79K-93.79%37.92K-33.85%1.33M-86.34%133.34K-38.54%243.17K92.79%435.25K
Research and development costs --0-98.92%3.1K100.02%2-99.88%94-98.58%655-98.67%2.35K--286.27K73.30%-13.27K176.84%77.41K133.14%46.01K
Other operating expenses -----99.18%2.02K-813.59%-8.2K-99.61%310--------214.01%246.38K-101.21%-89856,104.90%80.37K1,652.36%74.56K
Operating profit 0.76%-22.66K81.27%-348.48K37.31%-178.02K72.10%-85.21K85.92%-62.42K97.24%-22.84K18.19%-1.86M75.39%-283.95K29.42%-305.42K-65.82%-443.15K
Net non-operating interest income (expenses)
Other net income (expenses) 623.28%43.62K66.98%-2.42K109.26%1.57K183.32%48.05K-255.51%-3.58K99.90%-8.34K99.91%-7.33K-16.96K16.96K
Gain on sale of security -----90.57%181--0------------124.94%1.92K178.18%2.93K---16.96K--16.96K
Special income (charges) ----547.45%45.89K100.30%31--1.39K--48.05K---3.58K99.87%-10.26K---10.26K--------
-Less:Restructuring and mergern&acquisition ----------------------3.58K----------------
-Less:Impairment of capital assets ------0------------------37.26K------------
-Less:Other special charges -----69.95%-45.89K---31---1.39K-----------27K------------
Other non-operating income (expenses) -------2.45K--------------------------------
Income before tax 14.21%-22.66K83.69%-304.86K38.05%-180.44K74.06%-83.64K96.63%-14.37K96.81%-26.42K81.71%-1.87M96.80%-291.28K25.50%-322.38K-59.48%-426.2K
Income tax
Earnings from equity interest net of tax
Net income 14.21%-22.66K83.69%-304.86K38.05%-180.44K74.06%-83.64K96.63%-14.37K96.81%-26.42K81.71%-1.87M96.80%-291.28K25.50%-322.38K-59.48%-426.2K
Net income continuous operations 14.21%-22.66K83.69%-304.86K38.05%-180.44K74.06%-83.64K96.63%-14.37K96.81%-26.42K81.71%-1.87M96.80%-291.28K25.50%-322.38K-59.48%-426.2K
Noncontrolling interests
Net income attributable to the company 14.21%-22.66K83.69%-304.86K38.05%-180.44K74.06%-83.64K96.63%-14.37K96.81%-26.42K81.71%-1.87M96.80%-291.28K25.50%-322.38K-59.48%-426.2K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 14.21%-22.66K83.69%-304.86K38.05%-180.44K74.06%-83.64K96.63%-14.37K96.81%-26.42K81.71%-1.87M96.80%-291.28K25.50%-322.38K-59.48%-426.2K
Diluted earnings per share 14.19%-0.003482.14%-0.05-50.00%-0.0372.25%-0.013995.68%-0.002297.36%-0.00486.34%-0.2898.67%-0.0230.11%-0.05-13.16%-0.05
Basic earnings per share 14.19%-0.003482.14%-0.05-50.00%-0.0372.25%-0.013995.68%-0.002297.36%-0.00486.34%-0.2898.67%-0.0230.11%-0.05-13.16%-0.05
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data